---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-066098"
form_type: "8-K"
ticker: "BNBX"
cik: "0000744452"
company_name: "BNB PLUS CORP."
filed_at: "2024-05-29T23:59:59+00:00"
generated_at: "2026-06-01T07:50:02.781058+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Applied DNA Sciences prices $12M public offering of units with warrants subject to stockholder approval

## Summary
- Gross proceeds of ~$12M from 9,230,769 units at $1.30 per unit (or $1.2999 with pre-funded warrant).
- Each unit includes one share (or pre-funded warrant) plus two Series A and B warrants exercisable at $1.99 after stockholder approval.
- Proceeds to fund therapeutic DNA production services, MDx testing, and general corporate purposes.
- Offering closed May 29, 2024; Craig-Hallum and Laidlaw & Co. acted as placement agents.
- Warrants are not exercisable until stockholder approval obtained; special meeting planned within 90 days.

## SEC filing metadata
- accession: 0001104659-24-066098
- form_type: 8-K
- ticker: BNBX
- cik: 0000744452
- company_name: BNB PLUS CORP.
- filed_at: 2024-05-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/744452/000110465924066098/0001104659-24-066098-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/744452/000110465924066098/tm2415644d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-066098
- JSON: https://secwatch.observer/filing/0001104659-24-066098.json
- Plain text: https://secwatch.observer/filing/0001104659-24-066098.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.